Two large preoperative doses of erythropoietin do not reduce the systemic inflammatory response to cardiac surgery.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Cardiothoracic and Vascular Anesthesia

• Publication date

  2009-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.jvca.2008.08.018PMID 18948032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erythropoietin Improves Mood and Modulates the Cognitive and Neural Processing of Emotion 3 Days Post Administration

  2008cited by this paper
• Reduced Functional Deficits, Neuroinflammation, and Secondary Tissue Damage after Treatment of Stroke by Nonerythropoietic Erythropoietin Derivatives

  2007cited by this paper
• EPO tecting the Endothelium

  2007cited by this paper
• Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action.

  2007cited by this paper
• Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis.

  2007cited by this paper
• Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial

  2007cited by this paper
• Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin

  2007cited by this paper
• Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice.

  2007cited by this paper
• The release of systemic inflammatory mediators is independent of cardiopulmonary bypass temperature.

  2007cited by this paper
• Erythropoietin Enhances Hippocampal Response during Memory Retrieval in Humans

  2007cited by this paper
• EPO: renoprotection beyond anemia correction

  2006cited by this paper
• THE OCCURRENCE OF SEVERE SEPSIS AND SEPTIC SHOCK ARE RELATED TO DISTINCT PATTERNS OF CYTOKINE GENE EXPRESSION

  2006cited by this paper
• Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise.

  2006cited by this paper
• Erythropoietin decreases cytotoxicity and nitric oxide formation induced by inflammatory stimuli in rat oligodendrocytes.

  2006cited by this paper
• Novel applications of recombinant erythropoietin.

  2006cited by this paper
• Mechanisms of Disease: erythropoietin—an old hormone with a new mission?

  2006cited by this paper
• A Single Bolus of a Long-acting Erythropoietin Analogue Darbepoetin Alfa in Patients with Acute Myocardial Infarction: A Randomized Feasibility and Safety Study

  2006cited by this paper
• Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.

  2006cited by this paper
• Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.

  2006cited by this paper
• Beyond erythropoiesis: the anti-inflammatory effects of erythropoietin.

  2006cited by this paper
• Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion.

  2006cited by this paper
• Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1.

  2005cited by this paper
• Systemic inflammatory response to coronary artery bypass graft surgery.

  2005cited by this paper
• Modulation of Systemic Inflammatory Response after Cardiac Surgery

  2005cited by this paper
• Emerging biological roles for erythropoietin in the nervous system

  2005cited by this paper
• Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.

  2005cited by this paper
• Transcriptomic and Proteomic Patterns of Systemic Inflammation in On-Pump and Off-Pump Coronary Artery Bypass Grafting

  2005cited by this paper
• Pleiotropic renal actions of erythropoietin.

  2005cited by this paper
• Erythropoietin mimics ischemic preconditioning.

  2005cited by this paper
• New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics.

  2005cited by this paper
• Erythropoietin and myocardial protection: what's new?

  2005cited by this paper
• Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse.

  2005cited by this paper
• Emerging biological roles for erythropoietin in the nervous system

  2005cited by this paper
• Brain Natriuretic Peptide (BNP) in Patients Undergoing Coronary Artery Bypass Grafting

  2004cited by this paper
• ERYTHROPOIETIN ATTENUATES THE TISSUE INJURY ASSOCIATED WITH HEMORRHAGIC SHOCK AND MYOCARDIAL ISCHEMIA

  2004cited by this paper
• Side Effects of Cardiopulmonary Bypass:

  2004cited by this paper
• New treatment strategies for severe sepsis and septic shock

  2003cited by this paper
• Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

  2003cited by this paper
• Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal Apoptosis

  2003cited by this paper
• The Systemic Inflammatory Response to Cardiac Surgery: Implications for the Anesthesiologist

  2002cited by this paper
• Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial

  2002cited by this paper
• Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome

  2001cited by this paper
• Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

  2001cited by this paper
• Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

  2001cited by this paper
• The influence of recombinant human erythropoietin on tumor necrosis factor alpha and interleukin-10 production by whole blood cell cultures in hemodialysis patients.

  1998cited by this paper
• Sepsis and serum cytokine concentrations.

  1997cited by this paper
• Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.

  1996cited by this paper
• Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group.

  1995cited by this paper
• Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor‐α concentrations in patients undergoing cardiopulmonary bypass

  1993cited by this paper

• Effects of interventions targeting the systemic inflammatory response to cardiac surgery on clinical outcomes in adults.

  2023cites this paper
• Renal and Cerebral Hypoxia and Inflammation During Cardiopulmonary Bypass.

  2021cites this paper
• The effectiveness of olmesartan on inflammation at cardiopulmonary bypass

  2021cites this paper
• Quantitative and Qualitative Platelet Derangements in Cardiac Surgery and Extracorporeal Life Support

  2021cites this paper
• The Effect of Erythropoietin Administration on the Serum Level of YKL-40, pro-BNP and IL-6 in Coronary Surgery Patients

  2020cites this paper
• Risk factors of acute respiratory distress syndrome after on-pump cardiac surgery in the INFLACOR cohort study

  2020cites this paper
• The effects of Vitamin C on Inflammatory Markers and Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Surgery in Bushehr Heart Center: A Randomized Controlled Clinical Trial

  2020cites this paper
• The Preventive Role of Selenium in Inflammatory Response During Coronary Artery Bypass Graft Surgery: A Randomized, Controlled Clinical Trial

  2019cites this paper
• Understanding the human innate immune system : In-silico studies

  2019cites this paper
• Effects of Cardiopulmonary Bypass Temperature and Time on Inflammatory Response

  2019cites this paper
• Minimized extracorporeal circulation in non-coronary surgery.

  2019cites this paper
• Remote preconditioning might have protection for kidney in heart surgery

  2018cites this paper
• Prevalence and predictors of acute kidney injury after cardiac surgery: A single-centre retrospective study in Qatar

  2018cites this paper
• Impact of intraoperative cytokine adsorption on outcome of patients undergoing orthotopic heart transplantation—an observational study

  2018cites this paper
• Influence of the postoperative inflammatory response on cognitive decline in elderly patients undergoing on-pump cardiac surgery: a controlled, prospective observational study

  2017cites this paper
• Perioperative Management of Patients With End-Stage Renal Disease.

  2017cites this paper
• Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study.

  2016cites this paper
• Effects of Low-dose Selenium on the Inflammatory Response in Coronary Artery Bypass Graft Surgery: A Clinical Trial

  2016influential citation
• Humoral immune response and coated or uncoated oxygenators during cardiopulmonary bypass surgery

  2016cites this paper
• Effect of a Single Bolus of Erythropoietin on Renoprotection in Patients Undergoing Thoracic Aortic Surgery With Moderate Hypothermic Circulatory Arrest.

  2016cites this paper
• rhErythropoietin-b as a tissue protective agent in kidney transplantation: a pilot randomized controlled trial

  2015cites this paper
• High-sensitivity cardiac troponin T is more helpful in detecting peri-operative myocardial injury and apoptosis during coronary artery bypass graft surgery

  2015cites this paper
• Attenuating the Systemic Inflammatory Response to Adult Cardiopulmonary Bypass: A Critical Review of the Evidence Base.

  2014cites this paper
• Erythropoietin and Protection of Renal Function in Cardiac Surgery (the EPRICS Trial)

  2014cites this paper
• Die Wirkung von Erythropoietin auf die Thrombozytenfunktion im akuten Myokardinfarkt

  2014cites this paper
• Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety

  2013cites this paper
• Identification of inflammatory mediators and their modulation by strategies for the management of the systemic inflammatory response during cardiac surgery.

  2013cites this paper
• Effects of Erythropoietin on Blood Vessels and the Heart

  2013cites this paper
• Surgical outcome of Total Anomalous Pulmonary Venous Return

  2013cites this paper
• Early Serum Procalcitonin Level after Primary Total Hip Replacement

  2013cites this paper
• The Nociceptin System in Inflammation and Sepsis

  2013cites this paper
• Evaluation of the effect of one large dose of erythropoietin against cardiac and cerebral ischemic injury occurring during cardiac surgery with cardiopulmonary bypass: a randomized double‐blind placebo‐controlled pilot study

  2012cites this paper
• Organ-protective and immunomodulatory effects of erythropoietin--an update on recent clinical trials.

  2012cites this paper
• The Perioperative Effect of Ascorbic Acid on Inflammatory Response in Coronary Artery Bypass Graft Surgery; A Randomized Controlled Trial Coronary Artery Bypass Graft Surgery

  2012cites this paper
• Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions

  2012cites this paper
• Identification of Inflammatory Mediators and Their Modulation by Strategies for the Management of the Systemic Inflammatory Response During Cardiac Surgery

  2012cites this paper
• Haemodynamic goal-directed therapy in cardiac and vascular surgery. A systematic review and meta-analysis.

  2012cites this paper
• Erythropoietin does not attenuate renal dysfunction or inflammation in a porcine model of endotoxemia

  2011cites this paper
• Cortisol Exerts bi-phasic Regulation of Inflammation in Humans

  2011cites this paper
• Erythropoietin and the heart: facts and perspectives.

  2011cites this paper
• Protection tissulaire dans l'arrêt circulatoire : du massage cardiaque à la protection pharmacologique. Approche clinique et expérimentale

  2011cites this paper
• An investigation of EPO as a tissue protective agent in human kidney transplantation

  2011cites this paper
• Recombinant human erythropoeitin: efficacy and safety considerations for maximizing blood conservation in cardiac surgery.

  2011cites this paper
• Impaired Autoregulation of Cerebral Blood Flow During Rewarming from Hypothermic Cardiopulmonary Bypass and Its Potential Association with Stroke

  2010cites this paper
• Kardiale Protektion und Regeneration

  2010cites this paper
• Lung Dysfunction Following Cardiopulmonary Bypass

  2010cites this paper
• Apoptosis during CABG surgery with the use of cardiopulmonary bypass is prominent in ventricular but not in atrial myocardium

  2010cites this paper
• Determination of Pump Flow Rate During Cardiopulmonary Bypass in Obese Patients Avoiding Hemodilution

  2009cites this paper
• Influence of Methylprednisolone on Levels of Neuron‐Specific Enolase in Cardiac Surgery: A Corticosteroid Derivative to Decrease Possible Neuronal Damage

  2009cites this paper
• Adenosine A2A Receptor Hyperexpression in Patients With Severe SIRS After Cardiopulmonary Bypass

  2008influential citation
• Oxygenation and release of inflammatory mediators after off‐pump compared with after on‐pump coronary artery bypass surgery

  2007cites this paper